The frozen elephant trunk technique for the treatment of acute complicated Type B aortic dissection. (2nd August 2017)

• Record Type: Journal Article
• Authors: Kreibich, Maximilian; Berger, Tim; Morlock, Julia; Kondov, Stoyan; Scheumann, Johannes; Kari, Fabian A; Rylski, Bartosz; Siepe, Matthias; Beyersdorf, Friedhelm; Czerny, Martin
• Is Part Of: European journal of cardio-thoracic surgery. Volume 53:Number 3(2018)
• Page Start: 525
• Page End: 530
• Publication Date: 2017-08-02
• Subjects: Acute complicated Type B aortic dissection -- Frozen elephant trunk -- Surgical repair; Heart -- Surgery -- Periodicals; Chest -- Surgery -- Periodicals; 617.54
• DOI: 10.1093/ejcts/ezx281
• Languages: English
• ISSNs: 1010-7940

Abstract

Abstract: OBJECTIVES: Our goal was to report our preliminary results in patients with acute complicated Type B aortic dissection without a suitable landing zone for primary thoracic endovascular aortic repair who were treated with the frozen elephant trunk (FET) technique. METHODS: Within a 25-month period, 14 patients with acute complicated Type B aortic dissection underwent surgical repair using the FET technique. The reasons to perform the FET procedure were an ectatic ascending aorta/arch in 6 patients and the lack of an adequate landing zone in 8 patients. RESULTS: No deaths were observed. A non-disabling stroke occurred in 2 patients. Symptomatic spinal cord injury was not observed. The closure of the primary entry tear was successfully achieved in all patients. In 3 patients, a secondary distal thoracic endovascular aortic repair extension was performed during the same hospital stay. The median follow-up period was 6 ± 5 months. CONCLUSIONS: The FET technique is an attractive method for the repair of acute complicated Type B aortic dissection without a suitable landing zone for primary thoracic endovascular aortic repair. It should be considered as an alternative in patients who are at high risk for retrograde Type A aortic dissection, in patients with an unfavourable anatomy or in patients with connective tissue disease.